Cullinan Associates Inc. lessened its position in Gilead Sciences, Inc. ( NASDAQ:GILD – Get Rating ) by 20.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 119,259 shares of the biopharmaceutical company's stock after selling 30,923 shares during the period. Cullinan Associates Inc.'s holdings in Gilead Sciences were worth $10,238,000 as of its most recent SEC filing. A number of other institutional investors have also recently made changes to their positions in GILD.

https://www.dailypolitical.com/2023/03/19/cullinan-associates-inc-decreases-position-in-gilead-sciences-inc-nasdaqgild.html

#dailypolitical